Gene Panel Market at a CAGR of 21.36% to Estimated USD 8.22 Billion Growth by 2028
Research Reports
Apr 13, 2022
From 2021 to 2028, the global gene panel market is expected to increase at a CAGR of 21.36 percent, from USD 1.70 billion in 2020 to USD 8.22 billion in 2028.
A gene panel test is a type of genetic testing that sequences the entire genome of a patient accused of carrying diseases based on genetic abnormalities or that are genetically inherited, such as cancer, cardiovascular disease, and many others. Pharmacogenetics, congenital disease detection, and cancer risk assessment are just a few of the uses for gene panels.
A gene panel is a useful diagnostic tool for detecting and predicting rare genetic changes that spread diseases like Lynch Syndrome (hereditary non-polyposis colorectal cancer), which puts patients at a higher risk than other cancers like stomach, ovarian, and colon cancer. Targeted gene panels can be used to look for specific gene mutations linked to a disease or a phenotypic attribute that is being studied or researched. Recent breakthroughs in gene sequencing have resulted in the development of user-specific gene panels.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6100
Key Players
MRFR recognizes the following companies as the Key Players in the Global Gene Panel Market— Agilent Technologies Inc. (US), Thermo Fisher Scientific (US), F. Hoffmann-La Roche Ltd (Switzerland), Qiagen (Germany), Illumina Inc. (US), BGI Genomics (China), Integrated DNA Technologies, Inc. (the US), GENEWIZ (US), Novogene Corporation (US), Personalis, Inc. (the US), GATC Biotech AG (Germany), ArcherDX, Inc. (the US), GeneDx (Switzerland), and CENTOGENE AG (Germany).
Market Segmentation
Design, Application, Technique, and Geography are the four segments of the global Gene Panel Market.
Techniques for obtaining market data include:
- Amplicon-Based Methodology
- Hybridization-Based Methodology
The market is divided into two types of techniques: The amplicon-Based Approach and the Hybridization-Based Approach. The hybridization-based approach had the biggest market share and was expected to increase at a CAGR of 22.22 percent over the projection period.
Global Gene Panel Market, By Design
- Predesigned Gene Panels
- Customized Gene Panels
The Global Gene Panel Market has been split into Predesigned Gene Panels and Customized Gene Panels based on design.
Global Gene Panel Market, By Application
- Pharmacogenetics
- Cancer Risk Assessment
- Diagnosis of Congenital Disorders
- Others
Based on Application, the market is segmented into Pharmacogenetics, Diagnosis of Congenital Disorders, Cancer Risk Assessment, Others.
Regional Classification
The global gene panel market is divided into five regions: the Middle East, North America, Asia Pacific, Latin America, Europe, and Africa.
Because of increased collaborations and partnerships among industry participants, North America is likely to have a leading position in the global gene panel market over the forecast period. In October 2019, for example, Illumina, Inc., an American biotechnology company, and QIAGEN, a German molecular diagnostics company, established 15-year cooperation to expand the availability of next-generation sequencing-based clinical diagnostics for gene panels.
Industry News
Increased cancer cases of various sorts, such as cancer of the ovaries, fallopian tubes, breast cancer, prostate cancer in males, and rising global prevalence of chronic diseases, are driving the gene panel market. Furthermore, a growing number of initiatives by various companies throughout the world and other advantages of gene panels are important factors encouraging the gene panel market. On the other hand, strict policies and regulations for pharmaceutical companies and protection issues about genetic data are the major challenges faced by the gene panel market and hampering the growth.
One of the key reasons the area has become a primary medical service provider is its booming biotechnology industry and greater knowledge of new technologies. Even though gene panel testing is reliable, the test’s limitations and inaccuracy are predicted to stymie industry growth. Moreover, the market is expected to be stifled due to rigorous laws and safety concerns around gene panels. Regardless, continued genome sequencing research and innovation are projected to increase the demand for genetic testing.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/gene-panel-market-6100
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact Information:
Market Research Future (part of Wantstats Research and Media Private Limited), 99 Hudson Street,5Th Floor, New York, New York 10013, United States of America +1 646 845 9312 Email: sales@marketresearchfuture.com
Tags:
PR-Wirein, Wire, Research Newswire, English